⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9468778 | 0.81 | — | — | |
| SCHEMBL10822350 | 0.79 | — | — | |
| SCHEMBL306131 | 0.77 | BCHE (0.31) | — | |
| SCHEMBL10837828 | 0.77 | TSHR (0.31) | — | |
| SCHEMBL3822564 | 0.73 | MAPT (0.33) | — | |
| SCHEMBL5131740 | 0.73 | TSHR (0.33) | — | |
| SCHEMBL9833152 | 0.73 | KMT2A (0.42) | — | |
| SCHEMBL9220989 | 0.73 | — | — | |
| SCHEMBL609519 | 0.71 | TSHR (0.38) | — | |
| SCHEMBL1126983 | 0.71 | TSHR (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9770514-B2 | Tamper-resistant pharmaceutical dosage forms | ExxPharma Therapeutics LLC (US) | 2017-09-26 | — | — | US | claimed |
| US-20150064250-A1 | Tamper-Resistant Pharmaceutical Dosage Forms | ExxPharma Therapeutics LLC (US) | 2015-03-05 | — | — | US | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| US-10010620-B2 | Tamper-resistant pharmaceutical dosage forms and process for making same | ExxPharma Therapeutics LLC (US) | 2018-07-03 | — | — | US | disclosed |
| US-9770514-B2 | Tamper-resistant pharmaceutical dosage forms | ExxPharma Therapeutics LLC (US) | 2017-09-26 | — | — | US | disclosed |
| US-20160175454-A1 | Tamper-Resistant Pharmaceutical Dosage Forms and Process for Making Same | NEUROCRINE BIOSCIENCES, INC. | 2016-06-23 | — | — | US | disclosed |
| WO-2015034846-A1 | TAMPER-RESISTANT PHARMACEUTICAL DOSAGE FORMS AND PROCESS FOR MAKING SAME | ExxPharma Therapeutics LLC (US) | 2015-03-12 | — | — | WO | disclosed |
| US-20150064251-A1 | Tamper Resistant Dosage Form Composition And Process Of Making The Same | ExxPharma Therapeutics LLC | 2015-03-05 | — | — | US | disclosed |
| US-20150064250-A1 | Tamper-Resistant Pharmaceutical Dosage Forms | ExxPharma Therapeutics LLC (US) | 2015-03-05 | — | — | US | disclosed |
| US-7122198-B1 | Fast dissolving composition with prolonged sweet taste | PANACEA BIOTEC LIMITED (IN) | 2006-10-17 | — | — | US | disclosed |
| US-7026360-B1 | Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients | INPHARMA S.A. (CH) | 2006-04-11 | — | — | US | disclosed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | disclosed |
| US-6121218-A | CONTAINS ALCOHOL; ETHER; ORGANIC ACID, POLY ACID, ACID ANHYDRIDE, OR ACID HALIDE; UREA, THIOUREA OR DERIVATIVE THEREOF | THOMPSON ANDREW MICHAEL (US) | 2000-09-19 | — | — | US | disclosed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | disclosed |